Document is current
Any future updates will be listed below
-
Authors
Alhuseinalkhudhur, Ali https://orcid.org/0000-0002-1146-0534
Lubberink, Mark
Lindman, Henrik
Tolmachev, Vladimir
Frejd, Fredrik Y.
Feldwisch, Joachim
Velikyan, Irina
Sörensen, Jens
-
Funding
Funding for this research was provided by:
Cancerfonden (2016/835)
Bröstcancerfonden
- License Information
-
More Information
Article History
Received: 8 November 2019
Accepted: 31 January 2020
First Online: 23 March 2020
Ethics approval and consent to participate
: The clinical trial (EudraCT 2012-005228-14 and NCT01858116) was approved by the Regional Ethics Review Board in Uppsala (Dnr 2012/554), Radiation Protection Ethics Committee (Dnr D13/01), and Swedish Medical Products Agency (Dnr 151:2012/121491) []. All patients signed informed consent before inclusion in the study.
: All patients signed informed consent for publication before inclusion in the study.
: The authors declare that they have no competing interests.
